V CompBrief BY VELARION

Chief Culture Officer · NEOGENOMICS INC (NEO)

Gary Passman

FY2025 is the first fiscal year CompBrief holds for Gary Passman as a named executive officer of NEOGENOMICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$2,443,195

7th of 7 named executive officers at Neogenomics by FY2025 total.

7 named officers on file for NEOGENOMICS, FY2025

See an example →

What this number hides

The filing gives the total. NEOGENOMICS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how NEOGENOMICS’s whole pay program stands against its peers

  • NEOGENOMICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NEO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 6, 2026 (DEF 14A).

Free

Get Gary Passman’s full pay file as a PDF — free

More than this page: up to 10 years of Gary’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Gary Passman and every company like it: Velarion Intel, free for 3 days, no card →

Gary Passman compensation by year

NEOGENOMICS Summary Compensation Table · the one fiscal year held
In US dollars, as NEOGENOMICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$447,962
Bonus$75,000
Stock awards$1,124,995
Option awards$624,876
Non-equity incentive$164,000
Pension and deferred compensation$0
All other$6,362
Total$2,443,195

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEOGENOMICS INC DEF 14A filed April 6, 2026, accession 0001077183-26-000014, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NEOGENOMICS INC filed document, accession 0001077183-26-000014. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU52,698$619,728—
RSU39,588$465,555—
RSU15,972$187,831—
RSU15,536$182,703—
RSU12,723$149,622—
PSU11,651$137,016—
RSU11,651$137,016—
Option25,972—$16.45
Option89,542—$13.05
Option30,588—$11.74

Per the Outstanding Equity Awards at Fiscal Year-End table in NEOGENOMICS INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Change-in-control & termination

estimated payments NEOGENOMICS discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control and resignation for good reason$904,000$1,593,445$29,272$2,797,917
Involuntary termination without cause$452,000$857,704$29,272$1,610,176
Resignation for good reason, no change in control$452,000$857,704$29,272$1,610,176
Change in control and involuntary termination$904,000$1,593,445$29,272$2,797,917

Per the Potential Payments Upon Termination or Change in Control table in NEOGENOMICS INC's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

NEOGENOMICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Tony ZookDirector and Chief Executive Officer$9,127,092
Warren StonePresident and Chief Operating Officer$5,068,830
Jeffrey ShermanChief Financial Officer$4,681,428
Christopher SmithFormer Director and Former Chief Executive Officer$4,045,937
Melody HarrisFormer Chief Operations Officer and President, Oncology Data Solutions$3,692,445
Alicia OlivoExecutive Vice President, General Counsel & Business Development$3,049,999
Gary Passman · this pageChief Culture Officer$2,443,195

Gary Passman's compensation dossier, NEOGENOMICS

You have read Gary Passman's totals and holdings. The dossier adds each equity grant NEOGENOMICS disclosed for Gary Passman and NEOGENOMICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full NEOGENOMICS compensation record

free company brief
NEOGENOMICS INC (NEO) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within NEOGENOMICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NEOGENOMICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order NEOGENOMICS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEOGENOMICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order NEO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Gary Passman's compensation dossier